These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28318023)
1. Therapeutic disasters that hastened safety testing of new drugs. Paine MF Clin Pharmacol Ther; 2017 Apr; 101(4):430-434. PubMed ID: 28318023 [TBL] [Abstract][Full Text] [Related]
2. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Wax PM Ann Intern Med; 1995 Mar; 122(6):456-61. PubMed ID: 7856995 [TBL] [Abstract][Full Text] [Related]
4. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history. Bren L FDA Consum; 2001; 35(2):24-9. PubMed ID: 11444245 [No Abstract] [Full Text] [Related]
5. Sure cure: public policy on drug efficacy before 1962. Swann JP Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897 [No Abstract] [Full Text] [Related]
6. Access before approval--a right to take experimental drugs? Okie S N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545 [No Abstract] [Full Text] [Related]
7. Teaching clinicians about drugs--50 years later, whose job is it? Avorn J N Engl J Med; 2011 Mar; 364(13):1185-7. PubMed ID: 21449781 [No Abstract] [Full Text] [Related]
8. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids. Heymann LA Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670 [No Abstract] [Full Text] [Related]
9. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked? Shulman SR; Brown JS Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017 [No Abstract] [Full Text] [Related]
10. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study. Schwartz JL N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733 [No Abstract] [Full Text] [Related]
11. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA. Scheindlin S Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115 [No Abstract] [Full Text] [Related]
12. Regulation of drugs and devices: an evolution. Merrill RA Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161 [TBL] [Abstract][Full Text] [Related]
13. Show drugs work before selling them. Sipp D; McCabe C; Rasko JE Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530 [No Abstract] [Full Text] [Related]
14. Food and Drug Administration Drug Approval Process: A History and Overview. Williams CT Nurs Clin North Am; 2016 Mar; 51(1):1-11. PubMed ID: 26897420 [TBL] [Abstract][Full Text] [Related]
15. Changing requirements for evaluation of pharmacologic agents. Chesney RW; Christensen ML Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209 [TBL] [Abstract][Full Text] [Related]
16. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
17. Scientific and legal viability of follow-on protein drugs. Dudzinski DM; Kesselheim AS N Engl J Med; 2008 Feb; 358(8):843-9. PubMed ID: 18287608 [No Abstract] [Full Text] [Related]
18. Learning about the safety of drugs--a half-century of evolution. Avorn J N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034 [No Abstract] [Full Text] [Related]
19. Drug development history, "overview," and what are GCPs? Heilman RD Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867 [TBL] [Abstract][Full Text] [Related]
20. A history of drug development in four acts. Kinch MS; Hoyer D Drug Discov Today; 2015 Oct; 20(10):1163-8. PubMed ID: 25908577 [No Abstract] [Full Text] [Related] [Next] [New Search]